#United States #Boston #Patient Safety #Glytec #Jordan Messler

Glytec's Chief Medical Officer Honored for Patient Safety Leadership

Glytec, a leader in AI-driven diabetes management technologies, has recently announced that its Chief Medical Officer, Dr. Jordan Messler, has been recognized as one of Becker's Hospital Review's 2025 "Patient Safety Experts to Know." This distinguished list highlights 132 influential leaders nationwide committed to enhancing patient safety while fostering high-quality care within their healthcare organizations.

Dr. Messler's recognition stems from his consistent advocacy for patient safety, particularly in the fields of diabetes and glycemic management. His contributions have focused on the advancement of technology that complies with stringent FDA safety and effectiveness standards. At Glytec, he has led national initiatives to encourage hospitals and health systems in utilizing Glucommander®, the company’s innovative insulin dosing software integrated with electronic health records (EHRs). This digital solution is pivotal in reducing the risks associated with hyperglycemia and hypoglycemia—critical health complications that the Centers for Medicare & Medicaid Services (CMS) will closely monitor starting January 2026.

Under Dr. Messler's guidance, Glytec has demonstrated the impact of Glucommander® on patient outcomes, achieving fewer instances of hypoglycemic events, shorter hospital stays, and lower readmission rates, thereby delivering an impressive return on investment averaging 6 to 8 times. His experience in hospital settings has helped create turn-key solutions at Glytec, ensuring these technologies integrate seamlessly with existing IT systems, automate clinician workflows, and provide comprehensive analytics for improved patient care.

Commitment to Patient Safety
"Patient safety is at the core of our values at Glytec," said Patrick Cua, CEO of Glytec. "Dr. Messler's recognition by Becker's is a testament to our commitment towards equipping healthcare providers with the necessary tools to ensure safer and higher-quality care for every patient at every visit. We celebrate this honor alongside numerous other distinguished leaders who share our mission."

This accolade comes on the heels of Glytec’s multiple recognitions in 2025, including the prestigious Gold Stevie® Award for Healthcare Technology Company of the Year during the second annual Stevie Awards for Technology Excellence.

About Glytec
Glytec's groundbreaking, AI-powered technology platform is utilized by over 400 hospitals, enhancing collaborative diabetes management and insulin administration to boost patient outcomes, lessen hospital stays, and streamline clinical workflows. Notably, its flagship software, Glucommander®, represents the first FDA-approved cloud-based insulin management solution, blending into electronic medical records for an advanced clinical decision-making experience. Backed by over 100 patents and peer-reviewed publications, Glytec is dedicated to advancing patient care from hospital settings to home environments for patients, providers, and payors alike. For additional information, please visit Glytec or connect with them on LinkedIn.